Author:
Tefferi A,Al-Kali A,Begna K H,Patnaik M M,Lasho T L,Rizo A,Wan Y,Hanson C A
Publisher
Springer Science and Business Media LLC
Reference4 articles.
1. Tefferi A, Lasho TL, Begna KH, Patnaik MM, Zblewski DL, Finke CM et al. A pilot study of the telomerase inhibitor imetelstat for myelofibrosis. N Engl J Med 2015; 373: 908–919.
2. Broseus J, Alpermann T, Wulfert M, Florensa Brichs L, Jeromin S, Lippert E et al. Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis. Leukemia 2013; 27: 1826–1831.
3. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114: 937–951.
4. Cheson BD, Bennett JM, Kantarjian H, Pinto A, Schiffer CA, Nimer SD et al. Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood 2000; 96: 3671–3674.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献